We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

POC Hematology Analyzer for Oncology to Deliver Results in Five Minutes

By LabMedica International staff writers
Posted on 01 Jun 2022
Print article
Image: POC hematology analyzer will build upon novel deep-UV cell analysis technology (Photo courtesy of Cellia Science)
Image: POC hematology analyzer will build upon novel deep-UV cell analysis technology (Photo courtesy of Cellia Science)

Currently, blood cell differential testing relies on complex workflows involving expensive instruments, multiple reagents, extensive instrument calibration and maintenance, and operation by highly trained personnel. This results in long turn-around times that delay administration of critical treatments, such as chemotherapy, anti-psychotic medications, and blood transfusions. Now, a blood cell analyzer under development for CLIA-waived use at the point of care aims to provide neutrophil and platelet counts for chemotherapy patients at risk of neutropenia and thrombocytopenia.

The blood cell analyzer being developed by Cellia Science, Inc. (Fayetteville, AR, USA) has the potential to eliminate delays in providing patients with these critical treatments. The blood cell analyzer is based on label-free deep-UV imaging technology exclusively licensed from the Georgia Institute of Technology (Atlanta, GA, USA).

Hematology analysis is a prerequisite for a number of therapies. Cellia’s technology utilizes the inherent absorption of UV light by biomolecules within cells to generate high quality, label-free images. The use of low wavelength light and the direct detection of biomolecules enable better resolution than the traditional method of staining with Giemsa or similar dyes. While the initial device will be targeted towards oncology, this technology may be extended for use in any blood cell analysis application.

“While many point-of-care diagnostics involve trading accuracy or precision for convenience, preliminary studies implementing Cellia’s imaging technique resulted in high-quality images that provided excellent diagnostic power,” said Kelly Mabry, CEO of Cellia Science.

“Because our technology appears to achieve fast, reliable, quantitative, and simple blood cell analysis in a low-cost configuration, it has great potential to simplify and improve clinical hematological analysis,” said Dr. Francisco Robles, whose lab drove the development of a UV microscopy system that could be adapted for point of care use.

Related Links:
Cellia Science, Inc. 
Georgia Institute of Technology 

Gold Supplier
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
New
Silver Supplier
Monkeypox Virus Real Time PCR Test
Monkeypox Virus Real Time PCR Detection Kit
New
Urine Analyzer
H-500
New
D-Dimer Test
Epithod 616 D-Dimer Kit

Print article

Channels

Microbiology

view channel
Image: Trichinella sp. found in muscle tissue (Photo courtesy of McGill University)

Laboratory Features of Trichinellosis and Eosinophilia Threshold Determined

Trichinella nativa is a nematode worm, one of the species of the genus Trichinella, found in arctic and subarctic regions. It is highly pathogenic and has a high resistance to freezing. It is encapsulated,... Read more

Industry

view channel
Image: With Cell IDx’s acquisition, Leica Biosystems will be moving its multiplexing menu forward (Photo courtesy of Leica Biosystems)

Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling

Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.